Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin (Q33389566)

26 July 2017

title

Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin (English)

1 reference

26 July 2017

1 reference

M A Karsdal

1

1 reference

26 July 2017

I Byrjalsen

series ordinal

2

1 reference

26 July 2017

B J Riis

series ordinal

3

1 reference

26 July 2017

C Christiansen

series ordinal

4

1 reference

26 July 2017

publication date

4 December 2008

1 reference

BMC Clinical Pharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

8

1 reference

26 July 2017

page(s)

12

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6904-8-12

26 July 2017

exact match

0 references

cites work

Are nonresorbing osteoclasts sources of bone anabolic activity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Approaches to oral drug delivery for challenging molecules

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Gastroretentive drug delivery systems

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Thiomers for oral delivery of hydrophilic macromolecular drugs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Colonic drug delivery: an updated review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Oral delivery of salmon calcitonin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Transmucosal delivery systems for calcitonin: a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

The effect of oral calcitonin on cartilage turnover and surface erosion in an ovariectomized rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Chitosan-pentaglycine-phenylboronic acid conjugate: a potential colon-specific platform for calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

pH-sensitive microsphere delivery increases oral bioavailability of calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Reversible lipidization for the oral delivery of salmon calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Optimized chemical structure of nanoparticles as carriers for oral delivery of salmon calcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Oral delivery of insulin with the eligen technology: mechanistic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Carrier-enhanced human growth hormone absorption across isolated rabbit intestinal tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

The chloride channel inhibitor NS3736 [corrected] prevents bone resorption in ovariectomized rats without changing bone formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Mechanism of circadian variation in bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Optimising antiresorptive therapies in postmenopausal women: why do we need to give due consideration to the degree of suppression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6904-8-12

Circadian variation in serum CrossLaps concentration is reduced in fasting individuals.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2611964

Bone turnover and bone collagen maturation in osteoporosis: effects of antiresorptive therapies

31 October 2018

1 reference

12 December 2020

Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression

1 reference

12 December 2020

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen

1 reference

12 December 2020

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

1 reference

12 December 2020

Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood

1 reference

12 December 2020

Calcitonin induces podosome disassembly and detachment of osteoclasts by modulating Pyk2 and Src activities

1 reference

12 December 2020

Identifiers

DOI

10.1186/1472-6904-8-12

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6904-8-12

9 September 2019

1 reference

26 July 2017

1 reference